Simultaneous islet autotransplantation (IATx) can prevent diabetes in 30–40% of patients and improve glycemic control with insulin supplementation in an additional 30% of individuals leading to improvement in quality of life in the majority of patients [2]. The gene discussed is INS; the disease is diabetes mellitus.